1 signed distribution agreement (RIVIERA DIAMOND LLC). Uzbekistan Presidential Decree 35 (April 2025) caps exclusive distribution at 3 years; contract is 3.9 years old — exclusivity may have AUTO-EXPIRED June 2025 by operation of law. Verify within 60 days.
Country profile
Uzbekistan — regulatory context
Vet drug authority
National Center of Veterinary Diagnostics under Ministry of Agriculture; vet drug registration through state pharmaceutical agency.
Commercial agency / labor
New Labor Code 2025 — fixed-term contracts up to 5 years (become indefinite if extended, Art. 111). Probation up to 6 months. Distributor relationship typically subject to general civil code.
Termination compensation (labor)
Mandatory severance 50-200% average monthly salary depending on service length (Arts. 161 / 173). 2-month notice for redundancy.
FX rules
Central Bank of Uzbekistan — moderate liberalization since 2017; repatriation via authorized banks.
Sanctions / AML
Central Asia banking transit risk (same as Tajikistan).
Multi-distributor permissibility
CONDITIONALPresidential Decree No. 35 (Feb 2025; effective 1 Apr 2025) limits exclusive rights to ≤3 years, granted only via laws / Presidential decrees for specific purposes (security, health). Multiple "exclusive" distributors in non-restricted sectors are permitted under contract. Antimonopoly Committee scrutinizes territorial exclusivity to prevent unfair competition / trademark hijacking.
Voidance risks
Language law: No strict Russian / Uzbek requirement; foreign-language contracts valid if parties agree, but Uzbek translations needed for court enforcement.
Stamp duty: None required.
Commercial registry filing: No mandatory commercial-registry filing for distribution agreements; new LLC law (effective ~Jul 2026) modernizes governance.
FX repatriation (CRITICAL): Strict 90-180 day deadlines; non-compliance voids related payments / enforceability.
Notarization / apostille: Not required for standard distribution; apostille required for foreign documents in court (Uzbekistan is Hague Apostille member).
Exclusivity > 3 years: Post-April 2025 — void unless statutorily authorized; Antimonopoly Committee can nullify on unfair-competition / trademark-hijacking grounds.
GAPS to verify with Uzbek local counsel
Specific commercial agency / distributor protection law; vet drug registration fees and timelines.
Signed contracts in this country
RIVIERA DIAMOND LLC — abbreviated variant
Counterparty
RIVIERA DIAMOND LLC
Effective
5 June 2022
Term end
EXPIRED 5 February 2025 — 463 days ago Operating without paper.
Score / grade
52 / 100D
Template
Variant abbreviated — only 16 pages (vs 28 in Standard)
SKU count
Only 2 SKUs
Top 3 issues
Contract EXPIRED 5 Feb 2025 — 463 days ago; Feb 2025 MoU addresses debt + new PI only, not full renewal.
Uzbekistan Presidential Decree 35 (Apr 2025) — 3-year exclusivity cap. Contract is 3.9 years old. Exclusivity may have AUTO-EXPIRED June 2025 by operation of law.
Hybrid BANI/SIAC defect at Art. 34.2; 16-page abbreviated variant; name-order inconsistency (Teguh Yodiantara Prajitno vs Teguh Prajitno Yodiantara).
Authorized Products (Schedule A — expired; no separate LOA on file)
No standalone LOA on file. Product authorisation flows from Schedule A of the Distribution Agreement (signed 5 June 2022, expired 5 Feb 2025); October 2022 Amendment changed payment terms only, NOT Schedule A. 27 Feb 2025 MoU addresses debt and a new PI; does not amend Schedule A or constitute an LOA. Schedule A is silent for 2025 and beyond.
#
Product
Strain
Dose
2022 / 2023 / 2024 vol
CIF USD
1
Vaksimune AI Multi H5+H9
AI H5 + H9 multivalent
1000-dose vial
2,000 / 3,000 / 4,000
26.00
2
Vaksimune ND AI
ND + AI bivalent
1000-dose vial
2,000 / 3,000 / 4,000
25.00
Grand totals (doses): 2022 = 4,000 · 2023 = 6,000 · 2024 = 8,000 · 2025-onward = NULL (Schedule A silent). De facto product authorization currently operating without paper. Refresh Schedule A in replacement agreement (target by 31 July 2026).
Country watch items
Uzbekistan 3-year exclusivity cap — Presidential Decree 35
Priority: MEDIUM. Deadline: Within 60 days.
Uzbekistan Presidential Decree 35 (April 2025) caps exclusive distribution at 3 years unless statutorily authorized. JAPFA's Uzbekistan-Riviera Diamond LLC contract is effective 2022-06-05 — over 3.9 years old. Exclusive distribution rights may have auto-expired June 2025 by operation of Uzbek law.
Action: Verify with Uzbek local counsel whether Decree 35 grandfathered pre-2025 exclusive agreements. If not: (a) contract has effectively converted to non-exclusive by operation of law — JAPFA can appoint second Uzbek distributor immediately, (b) verify with Riviera whether they have continued operating as exclusive (estoppel argument), (c) renegotiate to either non-exclusive or seek statutory authorization for continued exclusivity.
Suggested actions ranked by urgency
60 days — verify Decree 35 effect
Verify with Uzbek local counsel whether Presidential Decree 35 grandfathered pre-2025 exclusive agreements.
If not grandfathered: contract has effectively converted to non-exclusive by operation of law — JAPFA can appoint second Uzbek distributor immediately.
Amendment No. 1
Fix dual BANI/SIAC forum at Art. 34.2.
Expand abbreviated template — currently 16 pages vs Standard 28.
Resolve name-order inconsistency Teguh Yodiantara Prajitno vs Teguh Prajitno Yodiantara.